In HER2-Postive Breast And Brain Cancer Patients Trastuzumab And Chemotherapy Improve

[News]

The use of trastuzumab, chemotherapy and surgery among women with HER2-positive metastatic breast cancer significantly improved survival from the time central nervous system metastases were diagnosed. Based on these study results, lead researcher Adam Brufsky, M.D., Ph.D...

More... (http://www.medicalnewstoday.com/releases/231244.php)